Advertisement
The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
  • E-mail E-Mail
  • Printer Friendly Printable Single-Page
  • Glossary Glossary
  • Bookmark and Share Share
U.S. Centers for Disease Control and Prevention • News Briefs

Haiti, Small Caribbean Islands to Get Cheaper HIV/AIDS Drugs

April 28, 2003


This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

Haiti and countries of the nine-nation Organization of Eastern Caribbean States will soon get brand-name antiretroviral drugs at a price of $500 per person each year, Edward Greene, the assistant secretary general of human and social development for the Caribbean Community, said Thursday. The Bill Clinton Foundation on HIV/AIDS and the Pan American Health Organization are assisting the Caribbean in negotiating cheaper prices for antiretroviral drugs with six leading pharmaceutical firms, Greene said. "We anticipate that Haiti will be fast-tracked also and that by the end of May, Haiti will be having even lower prices than the others given the level and nature of poverty," he said. Negotiators have already secured brand-name antiretroviral drugs for $800 for the other Caribbean countries, down from $1,000 that the region and drug companies last agreed to in July at the 14th International AIDS Conference in Spain.

Back to other CDC news for April 28, 2003

Previous Updates
 | Search the CDC archive


This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

Adapted from:
Agence France Presse
04.24.03

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
  • E-mail E-Mail
  • Printer Friendly Printable Single-Page
  • Glossary Glossary
  • Bookmark and Share Share

See Also
Read More About Generic/Discount HIV Drug Access in the Developing World
Read More About HIV/AIDS Drug Patents Policy

 

Advertisement